Investors / Neo Kuma Ventures
Neo Kuma Ventures
Venture capital
Neo Kuma Ventures is a venture capital firm that invests in psychedelic healthcare, including therapies for depression, anxiety and addiction. It backs science-led teams working on compounds, clinics and care delivery, and digital therapeutics and platforms.
Invests inHealthcare & Biotech
In its own wordspsychedelicsmental healthhealthcaredigital therapeuticsclinicslife sciences
Your fit with Neo Kuma Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNeo Kuma Ventures lists 11 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 57% of its companies are based in United States. It invests most often alongside Palo Santo, Iter Investments and PsyMed Ventures.
No funding round on record names Neo Kuma Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Neo Kuma Ventures' whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers982%
- No longer answers00%
- Points to another company218%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Neo Kuma Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| AtaiBeckley develops mental health treatments | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
Healthcare & Biotech | Portfolio page | |||
| Bright Minds develops drugs for mental health and neurology | Healthcare & Biotech | Portfolio page | ||
| Journey-Clinical provides ketamine-assisted psychotherapy and other psychedelic treatments for various mental health conditions. | Healthcare & Biotech | Portfolio page | ||
| Kadence Bio is a clinical-stage life sciences company developing novel therapeutics to address areas of significant unmet need in sexual and mental health. | Healthcare & Biotech | Portfolio page | ||
| Monument Therapeutics is a clinical-stage biotech company that develops targeted treatments for areas of high unmet need in psychiatry and neurology using digital biomarkers | Healthcare & Biotech | Portfolio page | ||
| Neurocentrx is developing a new drug- and software combination investigational product designed to offer a trusted prescription for psychiatrists and their patients to safely access the rapid-acting antidepressant effects of ketamine-based care. | Healthcare & Biotech | Portfolio page | ||
| Sana Health develops an audio-visual device for neuropathic pain relief | Healthcare & Biotech | Portfolio page | ||
| TRIPP provides AI powered mental wellness services | Healthcare & Biotech | Portfolio page | ||
| Wavepaths creates music for psychedelic therapy and other therapeutic practices | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- neokuma.co
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Neo Kuma Ventures' profile as data
Pull Neo Kuma Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/neokuma.co
# also
GET /v1/firms/neokuma.co/portfolio
GET /v1/firms/neokuma.co/coinvestors
GET /v1/firms/neokuma.co/news